Means of Communicating Through a Device

Quick Links

Disclose Your Invention
MTA/CDA Assistance
Technologies for Licensing
Industry Collaboration Opportunities
Research and Clinical Trials
Education Links
Office of Sponsored Research

Categories: “Research Tools

Reference #: 2017-009

OTC Contact: Ruchika Nijhara, Ph.D., MBA, CLP (Directory Information | Send a Message)




The compounds described in the present invention can be used as radioprotectors in the following settings:


Stage of Development

In-vivo studies demonstrate that the compounds can effectively protect rats and mice against ionizing radiation. Furthermore, Georgetown researchers have identified the mechanism of action of these compounds. They are currently studying the optimal dose schedule for these compounds for protection against total body irradiation.

Relevant Publications

Manuscript under preparation.

Patent Status

Patent application pending